Watch Pfizer’s $14 Billion Medivation Deal Boosts Cancer Drug Roster Business News Video

28 sec read

“Pfizer Inc (PFE.N), beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc (MDVN.O) for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company’s growing oncology roster.

“Medivation shares jumped nearly 20 percent to close at $80.42, just shy of the offer price of $81.50 per share. Shares of Pfizer, the largest U.S. drugmaker, were down 0.4 percent at $34.84.

“The offer is a 55-percent premium to Sanofi SA’s (SASY.PA) initial bid to buy Medivation for $52.50 per share in April, which pushed the San Francisco-based company to put itself up for sale.

“It represents a 118-percent increase since Reuters reported on March 30 that Medivation had hired JP Morgan to handle interest from companies in a potential acquisition.”

Read more at Reuters

Watch Netflix’s New ‘The Monster of Florence’ Official Teaser…

“Netflix has unveiled a fresh teaser trailer for Stefano Sollima’s four-part Italian crime drama The Monster of Florence as well as an October 22 launch date...
JM
20 sec read

Watch New ‘Superman’ Jeremy Jahns (Spoiler Free) Movie Review…

“Superman is officially flying into theaters this weekend, and following the Los Angeles premiere on Monday night came the first audience reactions as the...
JM
21 sec read

Watch Australia’s Mushroom Murderer Erin Patterson Convicted of Murder…

“Erin Patterson, the Australian woman accused of killing three relatives with a meal of death cap mushrooms baked in a Beef Wellington lunch, has...
JM
21 sec read